Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Finished Goods (2016 - 2025)

Historic Finished Goods for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $309.7 million.

  • Phibro Animal Health's Finished Goods rose 2142.72% to $309.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $309.7 million, marking a year-over-year increase of 2142.72%. This contributed to the annual value of $253.8 million for FY2025, which is 4968.98% up from last year.
  • Per Phibro Animal Health's latest filing, its Finished Goods stood at $309.7 million for Q4 2025, which was up 2142.72% from $279.6 million recorded in Q3 2025.
  • Over the past 5 years, Phibro Animal Health's Finished Goods peaked at $309.7 million during Q4 2025, and registered a low of $133.2 million during Q1 2021.
  • In the last 5 years, Phibro Animal Health's Finished Goods had a median value of $170.8 million in 2023 and averaged $190.6 million.
  • Per our database at Business Quant, Phibro Animal Health's Finished Goods tumbled by 299.96% in 2024 and then soared by 6375.72% in 2025.
  • Over the past 5 years, Phibro Animal Health's Finished Goods (Quarter) stood at $147.6 million in 2021, then rose by 16.81% to $172.4 million in 2022, then rose by 7.05% to $184.6 million in 2023, then soared by 38.16% to $255.0 million in 2024, then increased by 21.43% to $309.7 million in 2025.
  • Its last three reported values are $309.7 million in Q4 2025, $279.6 million for Q3 2025, and $253.8 million during Q2 2025.